Rule/Regulation Violated:
B. If an assisted living facility provides medication administration, a manager shall ensure that:
3. A medication administered to a resident:
b. Is administered in compliance with a medication order, and
Evidence/Findings:
Based on record review, observation, and interview, the manager failed to ensure a medication was administered in compliance with a medication order, for one of six residents reviewed. The deficient practice posed a risk if the resident experienced a change in condition due to improper administration of medication.
Findings include:
1. Review of R2's medical record revealed a current written service plan dated February 1, 2023. This service plan indicated R2 received medication administration.
2. Review of R2's medical record revealed a signed medication order dated March 28, 2023. This medication order stated "Metoprolol Tart 25mg Tab Take 1/2 tablet by mouth twice daily, Hold for SBP [Systolic Blood Pressure] less or equal to 110 or HR [Heart Rate] less than or equal to 60".
3. Review of R2's medical record revealed a May 2023 medication administration record (MAR). This MAR stated "Metoprolol Tart 25mg Tab Take 1/2 tablet by mouth twice daily, Hold for SBP less or equal to 110 or HR less than or equal to 60" and indicated the following:
-R2's SBP was recorded as 110 at 8am on May 19th, however, indicated 1/2 tab was administered.
-R2's HR was recorded as 60 at 4pm on May 20th, however, indicated 1/2 tab was administered.
-R2's HR was recorded as 60 at 4pm on May 21st, however, indicated 1/2 tab was administered.
4. During an observation of R2's medications, Metoprolol Tartrate 25mg was observed.
5. During an interview, E1, E2, E3, E4, E5, and E6 acknowledged R2's medication was not administered in compliance with the available medication order.
6. This is a repeat deficiency from the compliance inspection conducted June 6, 2022.
Summary:
No deficiencies were found during the on-site compliance inspection and investigation of complaints 00140957, 00138365, and 00137817 conducted on August 15, 2025.